(Q34791976)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190330%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Clinical pharmacokinetics of intranasal sumatriptan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190330%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190330%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Eliane Fuseau

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190330%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Olivier Petricoul

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190330%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Katy H P Moore

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190330%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Andrew Barrow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190330%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190330%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190330%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190330%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190330%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

801-811

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190330%20AND%20SRC:MED&resulttype=core&format=json

Absorption, pharmacokinetics and metabolism of 14C-sumatriptan following intranasal administration to the rat

12 November 2019

cites work

1 reference

12 December 2020

Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies

1 reference

12 December 2020

One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study

1 reference

12 December 2020

Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat.

1 reference

12 December 2020

The Clinical Pharmacology, Pharmacokinetics and Metabolism of Sumatriptan

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents

1 reference

12 December 2020

Mixed effect modeling of sumatriptan pharmacokinetics during drug development: II. From healthy subjects to phase 2 dose ranging in patients.

1 reference

12 December 2020

Classification of pediatric migraine: proposed revisions to the IHS criteria

1 reference

12 December 2020

off absorption, pharmacodynamics, metabolism and excretion of 14C-sumatriptan following intranasal administration to the beagle dog.

1 reference

12 December 2020

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

1 reference

12 December 2020

Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group

1 reference

12 December 2020

Single dose pharmacokinetics of sumatriptan in healthy volunteers

1 reference

12 December 2020

A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. The Finnish Sumatriptan Group and the Cardiovascular Clinical Research Group

1 reference

12 December 2020

Disposition of sumatriptan in laboratory animals and humans

1 reference

12 December 2020

Paroxetine treatment and the prolactin response to sumatriptan

1 reference

12 December 2020

1 reference

12 December 2020

Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration.

1 reference

12 December 2020

Treatment of Acute Migraine With Subcutaneous Sumatriptan

1 reference

12 December 2020

Lack of Pharmacokinetic Interaction Between Butorphanol Tartrate Nasal Spray and Sumatriptan Succinate

1 reference

12 December 2020

Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?

1 reference

12 December 2020

Pathophysiology of migraine--new insights.

1 reference

12 December 2020

Sumatriptan absorption from different regions of the human gastrointestinal tract

1 reference

12 December 2020

Nasal Cavity Enzymes Involved in Xenobiotic Metabolism: Effects on the Toxicity of Inhalants

1 reference

12 December 2020

Expression of CYP2A genes in rodent and human nasal mucosa.

1 reference

12 December 2020

Consistency of response to sumatriptan nasal spray across patient subgroups and migraine types

1 reference

12 December 2020

Lack of effect of flunarizine on the pharmacokinetics and pharmacodynamics of sumatriptan in healthy volunteers

1 reference

12 December 2020

Oral sumatriptan compared with placebo in the acute treatment of migraine

1 reference

12 December 2020

How does sumatriptan nasal spray perform in clinical practice?

1 reference

12 December 2020

Sumatriptan. An updated review of its use in migraine

1 reference

12 December 2020

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

1 reference

12 December 2020

IHS Criteria for Migraine and Tension-Type Headache in Children and Adolescents

1 reference

12 December 2020

Intranasal sumatriptan for the acute treatment of migraine. International Intranasal Sumatriptan Study Group

1 reference

12 December 2020

Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver

1 reference

12 December 2020

Oral sumatriptan in acute migraine

1 reference

12 December 2020

Sumatriptan nasal spray (20 mg/dose) in the acute treatment of cluster headache

1 reference

12 December 2020

Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies?

1 reference

12 December 2020

Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity

1 reference

12 December 2020

Lack of an interaction between propranolol and sumatriptan

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics of intranasally-administered dihydroergotamine in the rat

1 reference

12 December 2020

Sumatriptan clinical pharmacokinetics

1 reference

12 December 2020

Current and emerging second-generation triptans in acute migraine therapy: a comparative review

1 reference

12 December 2020

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

12 December 2020

Nasal absorption of dihydroergotamine from liquid and powder formulations in rabbits

1 reference

12 December 2020

Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies

1 reference

12 December 2020

Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses

1 reference

12 December 2020

Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache

1 reference

12 December 2020